We are live on ! Find out more
BIOSW

BioPlus Acquisition Corp. Warrants
BIOSW

Delisted

BIOSW was delisted on the 6th of October, 2023.

Back to rankings

44 hedge funds and large institutions have $1.35M invested in BioPlus Acquisition Corp. Warrants in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

2% more funds holding

Funds holding: 43 → 44 (+1)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

76% less capital invested

Capital invested by funds: $5.67M → $1.35M (-$4.33M)

Holders
44
Holders Change
+1
Holders Change %
+2.33%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
7
Closed
2
Calls
$866K
Puts
–
Net Calls
+$866K
Net Calls Change
-$1.14M

Top Buyers

Rank Fund Capital Flow
1
SFM
Spartan Fund Management
Canada
+$44.7K
2
CAC
Cowen and Company
New York
+$33.3K
3
HIM
HGC Investment Management
Ontario, Canada
+$20.7K
4
SCM
Shaolin Capital Management
Florida
+$10.3K
5
Walleye Capital
Walleye Capital
New York
+$6.62K

Top Sellers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
-$3.56M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$6.43K
3
KL
KIM LLC
Kansas
-$3.13K
4
CS
Clear Street
New York
-$1.31K
5
CSS
Cubist Systematic Strategies
Connecticut
-$952
Name Holding Trade Value Shares
Change 		Change in
Stake
AMH
26
Apollo Management Holdings
New York
$18.4K – – –
LP
27
LMR Partners
United Kingdom
$18.4K – – –
TCM
28
Tenor Capital Management
New York
$18.4K – – –
EFI
29
EHP Funds Inc
Canada
$17.4K – – –
CCM
30
Context Capital Management
California
$15K – – –
WAM
31
Wolverine Asset Management
Illinois
$15K – – –
Walleye Capital
32
Walleye Capital
New York
$14.1K +$6.62K +63,996 +201%
PMAM
33
Picton Mahoney Asset Management
Ontario, Canada
$10K – – –
WA
34
Whitebox Advisors
Minnesota
$9.21K – – –
YCM
35
Yakira Capital Management
Connecticut
$6.97K – – –
RCM
36
Rivernorth Capital Management
Florida
$6.46K +$5.14K +49,678 New
BCL
37
Bracebridge Capital LLC
Massachusetts
$3.69K +$2.59K +25,000 New
Walleye Trading
38
Walleye Trading
New York
$2.65K – – –
OAC
39
OMERS Administration Corp
Ontario, Canada
$2.46K – – –
SAMU
40
SONA Asset Management (US)
New York
$2.21K – – –
RCM
41
Robinson Capital Management
Michigan
$2.11K -$28 -275 -2%
TI
42
Tidal Investments
Wisconsin
$2K -$28 -275 -2%
LCM
43
Landscape Capital Management
New Jersey
$1.9K +$1.33K +12,862 New
DCM
44
Dupont Capital Management
Delaware
$1.71K – – –
AA
45
Ancora Advisors
Ohio
$129 – – –
MP
46
Mangrove Partners
Connecticut
– -$3.56M -341,144 Closed
Balyasny Asset Management
47
Balyasny Asset Management
Illinois
– -$6.43K -75,000 Closed
1
2

BIOSW Hedge Fund Activity: Q2 2023 in Review

44 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Warrants (BIOSW) for Q2 2023, worth a combined $1.35M — down 76% from $5.67M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BIOSW positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 7 trimmed.

The largest buyer was Spartan Fund Management, adding an estimated $44.7K. The largest seller was Mangrove Partners, exiting entirely with an estimated $3.56M sold.

  • 44 institutional investors held BioPlus Acquisition Corp. Warrants (BIOSW) as of Q2 2023, up from 43 in Q1 2023.
  • Funds reported $1.35M of BioPlus Acquisition Corp. Warrants stock for Q2 2023, down 76% quarter-over-quarter.
  • 4 funds opened new BioPlus Acquisition Corp. Warrants positions in Q2 2023 and 2 closed out, a net change of +2 holders.
  • The largest BioPlus Acquisition Corp. Warrants buyer in Q2 2023 was Spartan Fund Management, an estimated $44.7K added.
  • The largest BioPlus Acquisition Corp. Warrants seller in Q2 2023 was Mangrove Partners, an estimated $3.56M sold.

Based on aggregated 13F filings for Q2 2023.